Search research articles
Contact Us
Filters
Showing results (91-100 of 115) with videos related to
Page
of 12
Sort By:
Cancers
|
April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Journal of Racial and Ethnic Health Disparities
|
March 23, 2026
Cancer-Specific and Other-Cause Mortality of Asian Pacific Islanders vs. Caucasians Across Eleven Primary Cancers
Natali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
BJU International
|
October 10, 2025
Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy
Andrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Urology Oncology
|
April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives
Mattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
Cancers
|
June 10, 2023
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence
Mara Bacchiani, Vincenzo Salamone, Eleana Massaro, et al.
World Journal of Urology
|
May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancer
Quynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery
|
May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancers
Francesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
BJU International
|
May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study
Mattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International
|
January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results
Pietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology
|
February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes
Mattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 115) with videos related to
Sort By:
Page
of 12
Cancers
|
April 14, 2025
Adverse In-Hospital Outcomes Following Robot-Assisted vs. Open Radical Prostatectomy in Quadragenarians
Fabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Journal of Racial and Ethnic Health Disparities
|
March 23, 2026
Cancer-Specific and Other-Cause Mortality of Asian Pacific Islanders vs. Caucasians Across Eleven Primary Cancers
Natali Rodriguez Peñaranda, Francesco Di Bello, Andrea Marmiroli, et al.
BJU International
|
October 10, 2025
Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy
Andrea Marmiroli, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Urology Oncology
|
April 9, 2025
Oncological Outcomes in Bacillus Calmette-Guérin-naïve High-risk Non-muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives
Mattia Longoni, Pietro Scilipoti, Francesco Soria, et al.
Cancers
|
June 10, 2023
Assessing the Performance of 18F-FDG PET/CT in Bladder Cancer: A Narrative Review of Current Evidence
Mara Bacchiani, Vincenzo Salamone, Eleana Massaro, et al.
World Journal of Urology
|
May 4, 2025
Effect of chemotherapy on cancer specific mortality in female locally advanced urethral cancer
Quynh Chi Le, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
Journal of Robotic Surgery
|
May 7, 2025
Costs of robot-assisted vs. open approaches for 5 major cancers
Francesco Di Bello, Natali Rodriguez Peñaranda, Andrea Marmiroli, et al.
BJU International
|
May 22, 2025
Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study
Mattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
BJU International
|
January 11, 2025
Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results
Pietro Scilipoti, Mattia Longoni, Mario de Angelis, et al.
European Urology Oncology
|
February 20, 2026
Real-world Adherence to European Association of Urology-recommended Non-muscle-invasive Bladder Cancer Management: From Evidence-based Practice to Oncological Outcomes
Mattia Longoni, Pietro Scilipoti, Mario De Angelis, et al.
Page
of 12